Epiregulin is a member of the epidermal growth factor family.

An essential constituent appeared to be a substance called epidermal growth factor.

In various research epidermal growth factor has been shown to reduce fine lines, wrinkles and sagging.

That's short for "human epidermal growth factor receptor 2."

Epidermal growth factor receptor has been shown to interact with:

Growth cycles are controlled by a chemical signal like epidermal growth factor.

The epidermal growth factor receptor system, as such, has been used as an intermediate example.

For example, epidermal growth factor stimulates cells of the top layer of skin.

But about 15 of 1,000 cells responded to the bracing effects of epidermal growth factor.

It blocks a protein called epidermal growth factor that helps cancer cells grow and multiply.

Both drugs aim to block a cancer-spurring protein called epidermal growth factor receptor.

The lack of understanding is shown in the case of drugs that block the epidermal growth factor receptor.

He isolated the nerve growth factor and then discovered the epidermal growth factor.

They have been successfully used to identify dynamic changes in the phosphorylation status of more than 6000 sites after stimulation with epidermal growth factor.

Cetuximab (marketed as Erbitux) targets the epidermal growth factor receptor.

Furthermore, epidermal growth factor receptor plays a crucial role in tumorigenesis, which is the production of a new tumor.

Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma.

This endosomal protein regulates the cell-surface expression of epidermal growth factor receptor.

Erlotinib inhibits epidermal growth factor receptor, and works through a similar mechanism as gefitinib.

In the trial, epidermal growth factor receptor showed a rapid response to the inhibitor, as demonstrated by the improvement of the cancer symptoms.

GAPVD1 is also involved in the degradation of the epidermal growth factor receptor.

One of them was a gene called HER-2, human epidermal growth factor receptor No. 2.

The drug works by blocking activation of a molecule called epidermal growth factor receptor, which causes tumor cells to grow.

Whether your breast cancer cells contain high levels of human epidermal growth factor (HER-2/neu).

It suppresses the phosphorylation of the epidermal growth factor receptor in human colon carcinoma cells.